However, it is unlikely that the effects of ghrelin on bone are exclusively mediated through a GH/IGF-1 axis since ghrelin administration increases bone mass in genetically GH-deficient rats [5]. The gene discussed is IGF1; the disease is hyperinsulinemic hypoglycemia, familial, 4.